Skip to main navigation
Skip to main content
Skip to Footer
US
Sandoz Site Directory
Home
Our Work
What We Do
Disease Areas
Quality Generics
Biosimilars
Partnerships and Collaborations
Access to Healthcare
About Us
Who We Are
Corporate Responsibility
For Novartis Investors
Contact Us
Doing Business Responsibly
Patients & Customers
Report Side Effects
Product Safety Notices
Information for Customers
Products
News
US Press Releases & News
Media Contacts
Publications
Careers
Job Search
Working at Sandoz US
Diversity & Inclusion
Search
All News
Advanced Search
Basic Search
From Date:
To Date:
Show:
All
Featured News
Media Releases
In the News
Filter By
2020
October
Media Release
/
Oct 06, 2020
Sandoz Zarxio® demonstrates cost-effectiveness for breast cancer patients at intermediate risk when used as primary prophylaxis to decrease the incidence of febrile neutropenia following first-round of chemotherapy
Read More
Media Release
/
Oct 01, 2020
Sandoz launches its first RFID-tagged critical injectable medicines with Kit Check to optimize supply chain and automate restocking in US hospitals
Read More
August
Media Release
/
Aug 10, 2020
Sandoz launches Ciprofloxacin + Dexamethasone otic suspension in US for treatment of middle and outer ear bacterial infections
Read More
July
Media Release
/
Jul 13, 2020
Sandoz launches generic antibiotic Daptomycin in US, strategically growing injectables portfolio and strengthening hospital offering
Read More
Media Release
/
Jul 07, 2020
Sandoz collaborates with Civica Rx to help reduce critical generic medicine shortages in US hospitals
Read More
Media Release
/
Jul 01, 2020
Sandoz reviewing options after Federal Circuit upholds lower court ruling in biosimilar Erelzi® case
Read More
June
Media Release
/
Jun 15, 2020
Novartis manufactures and donates 27,000 units of hand sanitizer to New York State
Read More
May
Media Release
/
May 13, 2020
Sandoz Glatopa® demonstrates trend towards lower relapse rates and costs for MS patients in US compared to originator medicine in real-world study
Read More
April
Media Release
/
Apr 02, 2020
Novartis announces mutual agreement to terminate sale of Sandoz US generic oral solids, dermatology portfolio to Aurobindo
Read More
March
Media Release
/
Mar 30, 2020
Novartis donates 20,000 doses of hydroxychloroquine for COVID-19 PEP clinical trial
Read More
Search Results Navigation
First page
« first
Previous page
‹ previous
Page
1
of 5
Page
2
of 5
Current page
3
of 5
Page
4
of 5
Page
5
of 5
…
Next page
next ›
Last page
last »
Twitter
Tweet
Facebook
Share
Share
Twitter
Facebook
LinkedIn
Email
Jump to Comments
Print
Save
You are here
Home
›
News
›